Entero Therapeutics (ENTO) Stock Chart & Stock Price History $0.67 -0.01 (-1.46%) (As of 11/4/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFinancialsInsider TradesSEC FilingsShort InterestTrends Entero Therapeutics Stock Price Performance5 Day Performance+10.56%1 Month Performance+12.42%3 Month Performance+5.06% Receive ENTO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Entero Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyRigged election? Porter Stansberry’s viral Breaking Point 2024 broadcast has now been by tens of thousands of Americans who finally understand the grim reality of our next election. With November 5 just around the corner, it’s imperative for your financial future that you read Porter’s message below now and then watch Breaking Point before it’s too late. Watch this video, it is being taken down Monday night ENTO Stock Chart for Monday, November, 4, 2024 ENTO Chart by TradingView Entero Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/04/2024$0.69$0.67-2.01%$0.72$0.6392,983 shs$3.21 million11/01/2024$0.64$0.69+7.50%$0.72$0.65107,741 shs$3.27 million10/31/2024$0.61$0.64+4.95%$0.65$0.6148,268 shs$3.04 million10/30/2024$0.60$0.61+1.63%$0.61$0.5839,079 shs$1.51 million10/29/2024$0.58$0.60+3.64%$0.63$0.53224,747 shs$1.49 million10/28/2024$0.63$0.58-8.23%$0.69$0.57251,849 shs$1.43 million Get the Latest News and Ratings for ENTO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Entero Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/25/2024$0.68$0.63-7.24%$0.72$0.63103,617 shs$1.56 million10/24/2024$0.61$0.68+12.40%$0.75$0.62277,781 shs$1.68 million10/23/2024$0.62$0.61-1.87%$0.63$0.5859,404 shs$1.50 million10/22/2024$0.68$0.62-9.34%$0.65$0.59254,180 shs$1.53 million10/21/2024$0.74$0.68-8.03%$0.78$0.66261,574 shs$1.68 million10/18/2024$0.73$0.74+1.68%$0.87$0.66569,618 shs$1.83 million10/17/2024$0.56$0.73+29.88%$0.73$0.541.15 million shs$1.80 million10/16/2024$0.45$0.56+24.15%$0.64$0.451.19 million shs$1.39 million10/15/2024$0.45$0.45-0.79%$0.49$0.45120,794 shs$1.12 million10/14/2024$0.47$0.45-3.69%$0.48$0.42144,380 shs$1.13 million10/11/2024$0.40$0.47+17.41%$0.51$0.41363,095 shs$1.17 million10/10/2024$0.42$0.40-4.26%$0.44$0.39133,071 shs$995,000.0010/09/2024$0.42$0.42+0.21%$0.47$0.38296,415 shs$1.04 million10/08/2024$0.52$0.42-19.41%$0.58$0.401.12 million shs$1.04 million10/07/2024$0.60$0.52-13.31%$0.72$0.502.08 million shs$1.29 million10/04/2024$0.35$0.60+72.13%$0.75$0.3610.20 million shs$1.48 million10/03/2024$0.33$0.35+6.67%$0.37$0.3424,825 shs$862,000.0010/02/2024$0.32$0.33+2.06%$0.34$0.3247,337 shs$808,000.0010/01/2024$0.34$0.32-7.08%$0.35$0.3239,223 shs$792,000.0009/30/2024$0.34$0.34+0.20%$0.35$0.3338,130 shs$852,000.0009/27/2024$0.35$0.34-1.21%$0.35$0.3426,558 shs$851,000.0009/26/2024$0.34$0.35+2.32%$0.35$0.3329,659 shs$861,000.0009/25/2024$0.32$0.34+7.56%$0.35$0.3234,740 shs$842,000.0009/24/2024$0.31$0.32+1.64%$0.33$0.3162,571 shs$782,000.0009/23/2024$0.33$0.31-5.76%$0.36$0.3149,966 shs$770,000.0009/20/2024$0.35$0.33-4.62%$0.37$0.3352,692 shs$817,000.0009/19/2024$0.34$0.35+1.76%$0.37$0.3492,877 shs$856,000.0009/18/2024$0.35$0.34-3.41%$0.38$0.3443,068 shs$842,000.0009/17/2024$0.37$0.35-3.85%$0.38$0.3432,221 shs$871,000.0009/16/2024$0.35$0.37+4.90%$0.39$0.31114,551 shs$906,000.0009/13/2024$0.33$0.35+5.76%$0.39$0.33231,242 shs$1.13 million09/12/2024$0.44$0.33-25.00%$0.45$0.28272,524 shs$817,000.0009/11/2024$0.41$0.44+6.33%$0.45$0.4293,552 shs$1.09 million09/10/2024$0.40$0.41+3.45%$0.46$0.401.10 million shs$1.35 millionBlackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW09/09/2024$0.40$0.40+1.27%$0.42$0.3930,426 shs$1.30 million09/06/2024$0.40$0.40-2.30%$0.40$0.3646,824 shs$978,000.0009/05/2024$0.42$0.40-2.63%$0.43$0.3932,472 shs$1.00 million09/04/2024$0.42$0.42-1.14%$0.43$0.3819,556 shs$1.03 million09/03/2024$0.41$0.42+2.41%$0.44$0.3969,245 shs$1.04 million09/02/2024$0.41$0.41$0.44$0.4135,800 shs$1.02 million08/30/2024$0.42$0.41-1.68%$0.44$0.4135,808 shs$1.02 million08/29/2024$0.42$0.42-0.71%$0.45$0.4063,878 shs$1.03 million08/28/2024$0.44$0.42-3.43%$0.44$0.4194,074 shs$1.04 million08/27/2024$0.43$0.44+0.93%$0.46$0.43110,351 shs$1.08 million08/26/2024$0.41$0.43+4.64%$0.45$0.42155,078 shs$1.07 million08/23/2024$0.39$0.41+5.78%$0.43$0.35184,481 shs$1.02 million08/22/2024$0.42$0.39-7.29%$0.45$0.30373,080 shs$964,000.0008/21/2024$0.32$0.42+31.25%$0.44$0.251.21 million shs$1.04 million08/20/2024$0.30$0.32+7.60%$0.33$0.28339,174 shs$792,000.0008/19/2024$0.30$0.30-1.52%$0.31$0.28185,273 shs$736,000.0008/16/2024$0.30$0.30+1.38%$0.32$0.27309,383 shs$747,000.0008/15/2024$0.29$0.30+4.53%$0.30$0.27442,346 shs$737,000.0008/14/2024$0.29$0.29-0.11%$0.31$0.27385,275 shs$705,000.0008/13/2024$0.28$0.29+0.81%$0.33$0.261.10 million shs$706,000.0008/12/2024$0.24$0.28+19.06%$0.52$0.2422.12 million shs$700,000.0008/09/2024$0.24$0.24$0.25$0.21592,961 shs$588,000.0008/08/2024$0.62$0.24-61.85%$0.49$0.192.82 million shs$588,000.0008/07/2024$0.63$0.62-0.32%$0.75$0.6218,020 shs$1.54 million08/06/2024$0.65$0.63-3.83%$0.75$0.6217,021 shs$1.55 million08/05/2024$0.64$0.65+1.28%$0.68$0.5726,776 shs$1.61 million Related Companies Cardio Diagnostics Stock Chart Orgenesis Stock Chart BioCardia Stock Chart Shuttle Pharmaceuticals Stock Chart Jaguar Health Stock Chart Biomerica Stock Chart Hoth Therapeutics Stock Chart Eagle Pharmaceuticals Stock Chart Creative Medical Technology Stock Chart Genprex Stock Chart Receive ENTO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Entero Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ENTO) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entero Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Entero Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
